Neurourological Evaluation And Treatment In Children With Spinal Dysraphism
Abstract views: 69 / PDF downloads: 86
DOI:
https://doi.org/10.58600/eurjther.2008-14-2-1326-archKeywords:
Spinal dysraphism, Bladder dysfunction, Urodynamic evaluationAbstract
We aimed to clarify the neurourological findings in 117 children who have spinal dysraphism (SD). Between 1996 and 2006, age ranged 1-16 (mean 6.4) year, a total of 117 children ( 63 boys, 54 girls) were included to the study. Detailed history was taken from all patients and neuro-urologic examination had been performed. Urodynamic evaluation was done in the first admission and repeated at 3th,12 th and 24 th months. While we applied only medical treatment (oral anticholinergic and prophylactic antibiotics) to the 21 children, clean intermittent catheterization (CIC) had begun to the 55 children. Augmentation cystoplasty was performed in the 41 children who had been unsuccessful with medical treatment and/or CIC. While, normal findings were determine in the 78 (66.6%) of children, various degree of neurologic pathologies had establlished in the 39 of children. Early diagnosis is the most important factor for prevention of lower urinary system dysfunction and upper urinary system damage in children with SD. Urodynamic investigation is an obligation in urological evaluation and follow-up in this patient group. Patients should be evaluated together with pediatrics, neurochirurgii and orthopedy department in the management of treatment. , , .
Metrics
References
Pinar H, Tatevosyants N, Singer, D B. Central nervous system malformations in a perinatal/neonatal autopsies. Pediatr Dev Pathol. 1998;1:42-8.
Galloway NTM, Mekras JA, Helms M, WebsterGD. An objective score to predict upper tract deteriation in myelodysplasia. J Urol. 1991;145:535-7.
Sutherlve RS, Mevorach RA, Baskin LS, Kogan BA. Spinal dysraphism in children: an overwiew ve an approach to prevent complications. J Urol. 1995;46:294-304.
Rudy DC, Woodside JR. The incontinent myelodysplastic patients. Urol Clin North Am. 1991;18:295-308.
Perez LM, Barnes N, McDiarmid SA, Oakes WJ, Webster GD. Urological dysfunction in patient with diastamatomyelia. J Urol. 1993;149:1503-1505.
Sarica K, Erbagci A, Yagci F, Yurtseven C, Buyukbebeci O, Karakurum G. Multidiciplinary evaluation of occult spinal dysraphism in 47 children. Scan J Urol Nephrol. 2003;37(4):329-34.
Kataria R, Bajpai M, Lall A, Gupta DK, Grover VP, Mitra DK. Neurogenic bladder: urodynamic ve surgical aspects. Indian J Pediatr. 1997;64:68-71.
Sutherlve RS, Mevorach RA, Baskin LS, Kogan BA. Spinal dysraphism in children: an overview ve an aproach to prevent complications. Urology. 1995; 46:294-304.
Geroinotis E, Koff Sa, Enrile B. Prophylactic use of clean intermittent catheterization in treatment of infants ve young children with myelomeningocele ve neurogenic bladder dysfunction. J Urol. 1988;139:85-89.
Kasabian NG, Vlachiotis JD, Lais A, Klumpp B, Kelly MD, Siroky MB, Bauer SB. et al. The use of intravesical oksybutynin chloride in patients with detrusor hypertonicity ve dtrusor hyperrefleksia. J Urol. 1994;151:944-947.
Edelstein RA, Bauer SB, Kelly MD, Darbey MM, Peters CA, Atala A, Mandell J, Colodny AH, Retik AB. et al. The long-term urologic response of neonates with myelodysplasia treated proactively with intermittent catheterization ve anticholinergic therapy. J Urol. 1995;154:1500-1505.
Flood HD, Ritchey ML, Bloom Da, Huang C, McGuire EJ. et al. Outcome of refluks in children with myelodysplasia managed by bladder pressure monitoring. J Urol. 1994;152:1574-1578.
Bauer SB, Hallet M, Khoshbin S, Lebowitz RL, Winston KR, Gibson S, Colodny AH, Retik AB. et al. The predictive value of urodynamic evaluation in the newborn with myelodysplasia. JAMA. 1984;152:650-654.
Johnston LB, Borzyskowski M. Bladder dysfunction ve neurological disablity at presentation in closed spina bifida. Arch Dis Child. 1998;79:33-38.
Sakakibara R, Hattori T, Uchiyama T, Kamura K,Yamanishi T. Uroneurological assessment of spina bifida cystica occulta. Neurourol Urodynm. 2003;22:328-334.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 European Journal of Therapeutics
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The content of this journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.